ArticleAnti-cancer drugs2015

N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.

Ming-Che Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.